Dopamine Inhibits the Expression of Hepatitis B Virus Surface and e Antigens by Activating the JAK/STAT Pathway and Upregulating Interferon-stimulated Gene 15 Expression
View abstract on PubMed
Summary
This summary is machine-generated.Dopamine treatment effectively reduces hepatitis B virus (HBV) antigens, HBsAg and HBeAg, by activating the JAK/STAT pathway and boosting ISG15 expression. This finding offers a potential new therapeutic strategy for HBV infection.
Area Of Science
- Hepatology
- Virology
- Immunology
Background
- Hepatitis B virus (HBV) infection poses significant risks for cirrhosis and liver cancer, with challenging treatment options.
- Previous research indicated a dopamine analog's ability to inhibit HBV pregenomic RNA packaging into capsids.
Purpose Of The Study
- To investigate the impact of dopamine on hepatitis B virus surface antigen (HBsAg) and e antigen (HBeAg) expression.
- To elucidate the molecular mechanisms underlying dopamine's effect on HBV antigen production.
Main Methods
- Utilized dopamine-treated HBV-infected cell lines (HepG2.2.15, NTCP-G2) to assess HBsAg and HBeAg levels.
- Analyzed interferon-stimulated gene 15 (ISG15) expression and its role via knockdown experiments.
- Investigated the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway activation.
- Employed a mouse model of adeno-associated virus/HBV infection to evaluate in vivo effects.
Main Results
- Dopamine significantly inhibited HBsAg and HBeAg expression in cell lines and a mouse model.
- Dopamine treatment upregulated ISG15 expression, and ISG15 knockdown reversed the inhibitory effect on HBsAg and HBeAg.
- Dopamine activated the JAK/STAT pathway, leading to increased ISG15 expression and subsequent downregulation of HBV antigens.
Conclusions
- Dopamine effectively suppresses HBsAg and HBeAg expression in HBV infection.
- The mechanism involves dopamine-induced activation of the JAK/STAT pathway and subsequent upregulation of ISG15.
- This study highlights a novel therapeutic pathway for managing HBV infection.
Related Concept Videos
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

